Pola Pharma Inc.

Two more small biopharmaceutical companies managed to launch initial public offerings recently, bringing the 2022 total to 17 drug developers that have gone public in the US this year, despite the fac

As India and Japan seek to build on long-standing diplomatic and strategic ties, biopharma executives at a recent event highlighted the need for greater “alignment” on the regulatory front and also ce